Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pang, Yu ^a   Dong, Haiyan ^b   Tan, Yaoju ^c   Deng, Yunfeng ^d   Cai, Xingshan ^c   Jing, Hui ^d   Xia, Hui ^a   Li, Qiang ^a   Ou, Xichao ^a   Su, Biyi ^c   Li, Xuezheng ^d   Zhang, Zhiying ^b   Li, Junchen ^b   Zhang, Jiankang ^b   Huan, Shitong ^e   Zhao, Yanlin ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b PATH ^*  (China)

^c GUANGZHOU CHEST HOSPITAL   (China)

^d SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; KANAMYCIN; OFLOXACIN; RIFAMPICIN;

CHINA; CLINICAL TRIAL; DRUG EFFECTS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPUTUM;

AMIKACIN; CHINA; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; KANAMYCIN; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84966351259     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25330     Document Type: Article

References (36)

1. Zumla, A. et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis. 205, Suppl 2, S228-240 (2012).
2. Pai, M., Schito, M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis 211, Suppl 2, S21-28 (2015).
3. World Health Oragnization. Global tuberculosis report 2014. World Health Organization, Geneva, Switherland. WHO/HTM/TB/2014.08 (2014).
4. Wright, A. et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373, 1861-1873 (2009).
5. Van Rie, A., Enarson, D. XDR tuberculosis: an indicator of public-health negligence. Lancet 368, 1554-1556 (2006).
6. Nachega, J. B., Chaisson, R. E. Tuberculosis drug resistance: a global threat. Clin Infect Dis 36, S24-30 (2003).
7. Tagliani, E. et al. Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study. J Clin Microbiol 53, 2961-2969 (2015).
8. Pang, Y. et al. Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 51, 1707-1713 (2013).
9. Hoek, K. G., Van Rie, A., van Helden, P. D., Warren, R. M., Victor, T. C. Detecting drug-resistant tuberculosis: the importance of rapid testing. Mol Diagn Ther 15, 189-194 (2011).
10. Drobniewski, F., Nikolayevskyy, V., Balabanova, Y., Bang, D., Papaventsis, D. Diagnosis of tuberculosis and drug resistance: what can new tools bring us? Int J Tuberc Lung Dis 16, 860-870 (2012).
11. O'Grady, J. et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med 17, 134-141, doi: 10.1097/MCP.0b013e3283452346 (2011).
12. Ling, D. I., Zwerling, A. A., Pai, M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a metaanalysis. Eur Respir J 32, 1165-1174 (2008).
13. Boehme, C. C. et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363, 1005-1015 (2010).
14. Guo, Y. et al. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int J Tuberc Lung Dis 13, 914-920 (2009).
15. World Health Organization. The use of molecular line probe assay for the detection of resistance to second-line anti-tuberculosis drugs. World Health Organization, Geneva, Switherland. WHO/HTM/TB/2013.01 (2013).
16. Hu, S. et al. Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol 52, 1644-1652 (2014).
17. Zhang, T. et al. Evaluation of the MeltPro TB/STR assay for rapid detection of streptomycin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 95, 162-169 (2015).
18. Ma, Y. et al. Evaluation of the mutations detection of rpoB gene in Mycobacterium tuberculosis clinical isolates by probe melting analysis based real-time PCR. Chinese Frontier Health Quarantine 34, 451-454(2011).
19. Li, Q. et al. Multicenter Evaluation of the Molecular Line Probe Assay for Multidrug Resistant Mycobacterium Tuberculosis Detection in China. Biomed Environ Sci 28, 464-467 (2015).
20. Ou, X. et al. A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China. Int J Infect Dis 31, 41-46 (2015).
21. Chakravorty, S. et al. Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay. J Clin Microbiol 49, 932-940 (2011).
22. Zhang, X. et al. Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China. J Clin Microbiol 50, 1471-1474 (2012).
23. Zhang, X. et al. Co-occurrence of amikacin-resistant and-susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China. J Antimicrob Chemother 68, 1537-1542 (2013).
24. Chen, Q. et al. Molecular characteristics of MDR Mycobacterium tuberculosis strains isolated in Fujian, China. Tuberculosis (Edinb) 94, 159-161 (2014).
25. Mokrousov, I. et al. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother 52, 2937-2939 (2008).
26. Huang, T. S. et al. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother 56, 1058-1062 (2005).
27. Zhang, Z., Wang, Y., Pang, Y., Liu, C. Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58, 5632-5635 (2014).
28. Zhang, D., Liu, B., Wang, Y., Pang, Y. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. Trop Med Int Health 19, 1259-1266 (2014).
29. Zhao, L. L. et al. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. Antimicrob Agents Chemother 58, 3475-3480 (2014).
30. Rigouts, L. et al. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol 51, 2641-2645 (2013).
31. Koser, C. U. et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med 369, 290-292 (2013).
32. Ignatyeva, O. et al. Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study. J Clin Microbiol 50, 1593-1597 (2012).
33. Zhang, Z., Lu, J., Wang, Y., Pang, Y., Zhao, Y. Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene. Eur J Clin Microbiol Infect Dis 34, 555-560, doi: 10.1007/s10096-014-2262-0 (2015).
34. Zhang, Z. et al. Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Infect 70, 335-345 (2015).
35. Steingart, K. R. et al. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1, CD009593 (2013).
36. FIND. Non-inferiority Evaluation of Nipro NTM + MDRTB and Hain GenoType MTBDRplus V2 line probe assays. 4.1 (2015).